Investors

Home / Investors

View Petvivo's Corporate Slide Deck

$69.99

$49.99

STRONG

IP PORTFOLIO

Scalable

Production

Patented

TECHNOLOGY

Extensive

PRODUCT PIPELINE

Why Invest With PetVivo?

KUSH® is within a booming industry that continues to increase in growth, need, and sales.

$4.8B Market

Osteoarthritis (OA) affects 1 out of 4 dogs and over half of all horses . This is an addressable opportunity in companion animal OA therapeutics market.

Large and Growing Market

68% of US households own a pet and stats show a $99B US pet spend as of 2020.

Positioned to Scale

New facility, positioned to scale, with capacity to produce up 500K units annually = up to 100M in revenue.

Learn about our goals, our team, and our ground-breaking product, Kush®.

Click Here to scroll through PetVivo's corporate slide deck.

Petvivo Holdings, Inc. is a publicly traded company traded on the OTCQB: PETV.

View SEC filing documents here.

NEWS AND PRESS

Apr 28, 2021

PetVivo Awarded Key Biocompatible Stent Patent by the United States Patent and Trademark Office

Apr 16, 2021

Robert J. Folkes Joins PetVivo Holdings, Inc. as Chief Financial Officer

Dec 29, 2020

PetVivo Holdings, Inc. Announces Reverse Stock Split

Dec 7, 2020

PetVivo Holdings, Inc. to exhibit at the American Association of Equine Practitioners Virtual Convention and Trade Show

Nov 12, 2020

PetVivo Holdings, Inc. Announces Sponsored Research Agreement with Colorado State University for Osteoarthritis Treatment Study.

Oct 20, 2020

nScrypt Bioprints PetVivo® Biomaterial for Orthopedic Implants

FREQUENTLY ASKED QUESTIONS

What is PetVivo Holdings, Inc.?

PetVivo Holdings Inc. (OTCQB: PETV) is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The Company's strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics.

PetVivo has a pipeline of seventeen products for the treatment of animals and people. A portfolio of eighteen patents protects the Company's biomaterials, products, production processes and methods of use. The Company’s lead product Kush®, a veterinarian-administered, intraarticular injection for the treatment of osteoarthritis in dogs and horses, is scheduled for expanded commercial sale later this year.

What is Kush®?

Kush® is a veterinarian-administered, intraarticular injection for the treatment of osteoarthritis in dogs and horses.

Kush® uses precisely sized micro-particles for optimal joint spacing and for easy intra-articular injection with 18-23 gauge needles. Kush particles are too large to seep through synovial membranes, allowing long duration of their slippery cushion effects to reinforce the joint's articular cartilage and ameliorate or preclude the cartilage defects that cause pain to limit motion.

What is the difference between PetVivo and Kush®?

PetVivo Holdings, Inc. is the name of our company.
Kush® is the name of a product we provide.

How can I learn more about Kush® and Petvivo?

If you are a potential investor or have investor-related questions regarding Kush® or PetVivo, please contact PetVivo's president, John Lai at (952)-681-7681 or by email: JLAI@PETVIVO.COM

If you are a certified and licensed veterinarian, you can order Kush® here.

If you are an animal owner, Kush® is available for your animal through certain licensed and certified veterinarians. To locate a veterinarian in your area who can administer Kush® to your animal, please email us: INFO1@PETVIVO.COM

What if I have more questions?

We're ready to answer and address any questions or concerns. Whether by phone, e-mail, mail, and more, you can contact us here.